Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s disease
Abstract Background Emerging evidence indicates that inflammasome-induced inflammation plays a crucial role in the pathogenesis of Parkinson’s disease (PD). Several proteins including α-synuclein trigger the activation of NLRP3 inflammasome. However, few studies examined whether inflammasomes are ac...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Journal of Neuroinflammation |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12974-019-1670-6 |
id |
doaj-888a2de146aa4eaea0055985665be7a6 |
---|---|
record_format |
Article |
spelling |
doaj-888a2de146aa4eaea0055985665be7a62021-01-10T12:24:11ZengBMCJournal of Neuroinflammation1742-20942020-01-0117111010.1186/s12974-019-1670-6Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s diseaseZheng Fan0Yu-Ting Pan1Zhi-Yuan Zhang2Hui Yang3Shu-Yue Yu4Yan Zheng5Jing-Hong Ma6Xiao-Min Wang7Department of Pharmacology, School of Basic Medical Sciences, Capital Medical UniversityDepartment of Neurobiology, School of Basic Medical Sciences, Capital Medical UniversityDepartment of Neurobiology, School of Basic Medical Sciences, Capital Medical UniversityCore Facility Center, Capital Medical UniversityPreventive Medicine, School of Public Health, Capital Medical UniversityDepartment of Physiology, School of Basic Medical Sciences, Capital Medical UniversityDepartment of Neurology, Xuanwu Hospital of Capital Medical UniversityDepartment of Neurobiology, School of Basic Medical Sciences, Capital Medical UniversityAbstract Background Emerging evidence indicates that inflammasome-induced inflammation plays a crucial role in the pathogenesis of Parkinson’s disease (PD). Several proteins including α-synuclein trigger the activation of NLRP3 inflammasome. However, few studies examined whether inflammasomes are activated in the periphery of PD patients and their possible value in the diagnosis or tracking of the progress of PD. The aim of this study was to determine the association between inflammasome-induced inflammation and clinical features in PD. Methods There were a total of 67 participants, including 43 patients with PD and 24 controls, in the study. Participants received a complete evaluation of motor and non-motor symptoms, including Hoehn and Yahr (H-Y) staging scale. Blood samples were collected from all participants. The protein and mRNA expression levels of inflammasomes subtypes and components in peripheral blood mononuclear cells (PBMCs) were determined using western blotting and RT-qPCR. We applied Meso Scale Discovery (MSD) immunoassay to measure the plasma levels of IL-1β and α-synuclein. Results We observed increased gene expression of NLRP3, ASC, and caspase-1 in PBMCs, and increased protein levels of NLRP3, caspase-1, and IL-1β in PD patients. Plasma levels of IL-1β were significantly higher in patients with PD compared with controls and have a positive correlation with H-Y stage and UPDRS part III scores. Furthermore, plasma α-synuclein levels were also increased in PD patients and have a positive correlation with both UPDRS part III scores and plasma IL-1β levels. Conclusions Our data demonstrated that the NLRP3 inflammasome is activated in the PBMCs from PD patients. The related inflammatory cytokine IL-1β and total α-synuclein in plasma were increased in PD patients than controls, and both of them presented a positive correlation with motor severity in patients with PD. Furthermore, plasma α-synuclein levels have a positive correlation with IL-1β levels in PD patients. All these findings suggested that the NLRP3 inflammasome activation-related cytokine IL-1β and α-synuclein could serve as non-invasive biomarkers to monitor the severity and progression of PD in regard to motor function.https://doi.org/10.1186/s12974-019-1670-6NLRP3 inflammasomeInterleukin-1βα-SynucleinParkinson’s diseaseInflammation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Zheng Fan Yu-Ting Pan Zhi-Yuan Zhang Hui Yang Shu-Yue Yu Yan Zheng Jing-Hong Ma Xiao-Min Wang |
spellingShingle |
Zheng Fan Yu-Ting Pan Zhi-Yuan Zhang Hui Yang Shu-Yue Yu Yan Zheng Jing-Hong Ma Xiao-Min Wang Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s disease Journal of Neuroinflammation NLRP3 inflammasome Interleukin-1β α-Synuclein Parkinson’s disease Inflammation |
author_facet |
Zheng Fan Yu-Ting Pan Zhi-Yuan Zhang Hui Yang Shu-Yue Yu Yan Zheng Jing-Hong Ma Xiao-Min Wang |
author_sort |
Zheng Fan |
title |
Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s disease |
title_short |
Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s disease |
title_full |
Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s disease |
title_fullStr |
Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s disease |
title_full_unstemmed |
Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s disease |
title_sort |
systemic activation of nlrp3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in parkinson’s disease |
publisher |
BMC |
series |
Journal of Neuroinflammation |
issn |
1742-2094 |
publishDate |
2020-01-01 |
description |
Abstract Background Emerging evidence indicates that inflammasome-induced inflammation plays a crucial role in the pathogenesis of Parkinson’s disease (PD). Several proteins including α-synuclein trigger the activation of NLRP3 inflammasome. However, few studies examined whether inflammasomes are activated in the periphery of PD patients and their possible value in the diagnosis or tracking of the progress of PD. The aim of this study was to determine the association between inflammasome-induced inflammation and clinical features in PD. Methods There were a total of 67 participants, including 43 patients with PD and 24 controls, in the study. Participants received a complete evaluation of motor and non-motor symptoms, including Hoehn and Yahr (H-Y) staging scale. Blood samples were collected from all participants. The protein and mRNA expression levels of inflammasomes subtypes and components in peripheral blood mononuclear cells (PBMCs) were determined using western blotting and RT-qPCR. We applied Meso Scale Discovery (MSD) immunoassay to measure the plasma levels of IL-1β and α-synuclein. Results We observed increased gene expression of NLRP3, ASC, and caspase-1 in PBMCs, and increased protein levels of NLRP3, caspase-1, and IL-1β in PD patients. Plasma levels of IL-1β were significantly higher in patients with PD compared with controls and have a positive correlation with H-Y stage and UPDRS part III scores. Furthermore, plasma α-synuclein levels were also increased in PD patients and have a positive correlation with both UPDRS part III scores and plasma IL-1β levels. Conclusions Our data demonstrated that the NLRP3 inflammasome is activated in the PBMCs from PD patients. The related inflammatory cytokine IL-1β and total α-synuclein in plasma were increased in PD patients than controls, and both of them presented a positive correlation with motor severity in patients with PD. Furthermore, plasma α-synuclein levels have a positive correlation with IL-1β levels in PD patients. All these findings suggested that the NLRP3 inflammasome activation-related cytokine IL-1β and α-synuclein could serve as non-invasive biomarkers to monitor the severity and progression of PD in regard to motor function. |
topic |
NLRP3 inflammasome Interleukin-1β α-Synuclein Parkinson’s disease Inflammation |
url |
https://doi.org/10.1186/s12974-019-1670-6 |
work_keys_str_mv |
AT zhengfan systemicactivationofnlrp3inflammasomeandplasmaasynucleinlevelsarecorrelatedwithmotorseverityandprogressioninparkinsonsdisease AT yutingpan systemicactivationofnlrp3inflammasomeandplasmaasynucleinlevelsarecorrelatedwithmotorseverityandprogressioninparkinsonsdisease AT zhiyuanzhang systemicactivationofnlrp3inflammasomeandplasmaasynucleinlevelsarecorrelatedwithmotorseverityandprogressioninparkinsonsdisease AT huiyang systemicactivationofnlrp3inflammasomeandplasmaasynucleinlevelsarecorrelatedwithmotorseverityandprogressioninparkinsonsdisease AT shuyueyu systemicactivationofnlrp3inflammasomeandplasmaasynucleinlevelsarecorrelatedwithmotorseverityandprogressioninparkinsonsdisease AT yanzheng systemicactivationofnlrp3inflammasomeandplasmaasynucleinlevelsarecorrelatedwithmotorseverityandprogressioninparkinsonsdisease AT jinghongma systemicactivationofnlrp3inflammasomeandplasmaasynucleinlevelsarecorrelatedwithmotorseverityandprogressioninparkinsonsdisease AT xiaominwang systemicactivationofnlrp3inflammasomeandplasmaasynucleinlevelsarecorrelatedwithmotorseverityandprogressioninparkinsonsdisease |
_version_ |
1724343014212501504 |